Asian Startups Lose Confidence in U.S. Banking After SVB Panic
BusinessBank’s collapse underlines role of U.S. money in global tech financing Source link
Biotechnology
New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients
HealthMedicare won’t pay for medicine under rule issued to restrict use of earlier drug whose approval generated controversy Source link
Amgen Agrees to Deal to Buy Horizon Therapeutics
BusinessThe U.S. biotechnology company will pay $116.50 for each Horizon share Source link
Pfizer, Uber and Starbucks Highlight Another Busy Earnings Week
Pfizer Inc., PFE 3.69% Uber UBER -1.15% Technologies Inc. and Starbucks Corp. SBUX 2.13% are among the heavyweights headlining another...
Pfizer’s New Omicron-Targeting Booster Produces Strong Immune Response
The retooled Covid-19 booster from Pfizer Inc. and BioNTech SE generated a strong immune response against the Omicron substrains BA.4...
WSJ News Exclusive | CEO of Biotech Lobbying Group BIO on Leave Amid Clash Over Direction
The chief executive of the biotechnology industry’s top lobbying group in Washington is on leave amid dissent within the organization...
Alzheimer’s Drug Slows Disease Progression in Trial
The pharmaceutical companies said their drug lecanemab reduced cognitive and functional decline by 27%, compared with a placebo, over 18...
Biogen Agrees to Pay $900 Million Over Alleged Improper Physician Payments
Biogen Inc. agreed to pay $900 million to settle allegations that it paid kickbacks to doctors to induce them to...
Illumina-Grail Deal Blocked by EU’s Antitrust Regulator
BRUSSELS—The European Union blocked Illumina Inc.’s acquisition of Grail Inc., just days after the American life-sciences company won its case...
Illumina Wins Case Against FTC on Grail Acquisition
An administrative law judge has ruled in favor of Illumina Inc. ILMN -2.10% in its $7.1 billion acquisition of cancer-testing...
Covid-19 Booster Shots Targeting Omicron Authorized, Likely to Be Offered Soon
U.S. health regulators cleared use of retooled Covid-19 vaccines that target the latest versions of Omicron, in preparation for a...
U.K. Approves Covid-19 Booster Shot Aimed at Omicron
The U.K. became the first country to approve Moderna Inc.’s Omicron-targeting Covid-19 vaccine as a booster shot, paving the way...
Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics
Pfizer Inc. has agreed to buy Global Blood Therapeutics Inc. for $5.4 billion, in a deal that would give the...
WSJ News Exclusive | Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer Inc. PFE -1.18% is in advanced talks to buy Global Blood Therapeutics Inc., GBT 33.03% the maker of a...
Starbucks, Uber, CVS to Report Earnings Amid Shrinking Economy
About 30% of S&P 500 companies are slated to report earnings in the coming week, according to FactSet. Two Dow...
CDC Recommends Novavax’s Covid Vaccine for Adults 18 and Older
The Centers for Disease Control and Prevention on Tuesday recommended the use of Novavax Inc.’s Covid-19 vaccine, the final hurdle...
WSJ News Exclusive | Merck Deal for Seagen Seen as Unlikely by Earnings Release
Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized ahead of the pharmaceutical giant’s...
Pfizer’s Omicron-Targeting Covid-19 Vaccines Generate Stronger Immune Response
Pfizer Inc. and BioNTech SE vaccines modified to target the Omicron variant produced a significantly larger immune response than the...
WSJ News Exclusive | Merck Explores Purchase of Biotech Seagen
Merck MRK -0.32% & Co. is eyeing a purchase of biotech Seagen Inc., SGEN 12.72% according to people familiar with...
FDA Advisers Review Pfizer, Moderna Covid-19 Vaccines in Young Children
A positive recommendation would likely lead soon to expanding the U.S. Covid-19 vaccination campaign to the 19.6 million children 6...
